| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |